• Blood Biomarker “Clock” Detects Alzheimer’s Symptoms

    Clinical Research News | Researchers from the Foundation for the National Institutes of Health, Washington University in St. Louis, the University of California San Francisco, the University of Wisconsin-Madison, and other collaborators found that a plasma biomarker—the ratio of phosphorylated to non-phosphorylated plasma tau at position 217, written %p-tau217—can be used to construct a “clock model” that can predict when Alzheimer’s disease symptoms appear.

    Mar 26, 2026

  • Follow the Money: Brain-Computer Retinal Implant Trial Results, Alzheimer’s Platform Development, More

    Clinical Research News | Science Corporation’s PRIMA trial results are featured in The New England Journal of Medicine and on the cover of Time; Cognito Therapeutics continues to clinically develop their Spectris platform; and more.

    Mar 25, 2026

  • Verily, Samsung Partnership, Scite MCP Improves AI Trustworthiness, Johnson & Johnson Receives FDA Approval

    Clinical Research News | Verily Life Sciences and Samsung Electronics America enter a collaboration; Research Solutions launches Scite MCP; Johnson & Johnson receives approval from FDA for TECVAYLI and DARZALEX FASPRO; and more.

    Mar 24, 2026

  • Verily, Samsung Partnership, Scite MCP Improves AI Trustworthiness, Johnson & Johnson Receives FDA Approval

    Clinical Research News | Verily Life Sciences and Samsung Electronics America enter a collaboration; Research Solutions launches Scite MCP; Johnson & Johnson receives approval from FDA for TECVAYLI and DARZALEX FASPRO; and more.

    Mar 24, 2026

  • Is Agentic AI The ‘Next Leap Forward’ for Clinical Trial Data Management?

    Clinical Research News | Efforts to improve clinical trials for children with rare diseases must focus on ensuring flexibility while capturing the best data. Florence Mowlem, chief scientific officer at uMotif, joins the most recent episode of The Scope of Things to discuss how thoughtful study design—not just advanced technology—is essential for ensuring reliable data and strong patient participation.

    Mar 20, 2026

  • Is Agentic AI The ‘Next Leap Forward’ for Clinical Trial Data Management?

    Clinical Research News | In clinical trials, every second counts, both for patient outcomes and sponsor ROI. As data volumes grow and oversight expectations tighten under frameworks like ICH E6(R3), teams are being asked to do more, faster and with greater precision. It is no surprise then that agentic AI, which promises to deliver efficiencies far beyond previous models, is the current hot topic across the industry.

    Mar 20, 2026

  • The Brain’s Role in High Blood Pressure

    Clinical Research News | Hypertension, also known as high blood pressure, has long been thought of as primarily a disorder of the heart, kidneys, or blood vessels. A growing body of evidence suggests that, in a substantial proportion of patients, the condition originates in the brain.

    Mar 17, 2026

  • The Brain’s Role in High Blood Pressure

    Clinical Research News | Hypertension, also known as high blood pressure, has long been thought of as primarily a disorder of the heart, kidneys, or blood vessels. A growing body of evidence suggests that, in a substantial proportion of patients, the condition originates in the brain.

    Mar 17, 2026

  • Clinical Operations in 2030: What Will It Look Like?

    Clinical Research News | Clinical Operations is entering a phase where the hype around artificial intelligence (AI) and digital transformation is giving way to something more meaningful. For the last decade, much of the industry’s effort has focused on layering new technologies onto existing processes. By 2030, that approach will no longer be enough.

    Mar 13, 2026

  • Clinical Operations in 2030: What Will It Look Like?

    Clinical Research News | Clinical Operations is entering a phase where the hype around artificial intelligence (AI) and digital transformation is giving way to something more meaningful. For the last decade, much of the industry’s effort has focused on layering new technologies onto existing processes. By 2030, that approach will no longer be enough.

    Mar 13, 2026